Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 13
2003 11
2004 17
2005 13
2006 14
2007 14
2008 18
2009 16
2010 24
2011 24
2012 15
2013 31
2014 33
2015 50
2016 36
2017 36
2018 46
2019 42
2020 41
2021 37
2022 24
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Results by year

Filters applied: . Clear all
Page 1
Converging and evolving immuno-genomic routes toward immune escape in breast cancer.
Blanco-Heredia J, Souza CA, Trincado JL, Gonzalez-Cao M, Gonçalves-Ribeiro S, Gil SR, Pravdyvets D, Cedeño S, Callari M, Marra A, Gazzo AM, Weigelt B, Pareja F, Vougiouklakis T, Jungbluth AA, Rosell R, Brander C, Tresserra F, Reis-Filho JS, Tiezzi DG, de la Iglesia N, Heyn H, De Mattos-Arruda L. Blanco-Heredia J, et al. Among authors: rosell r. Nat Commun. 2024 Feb 21;15(1):1302. doi: 10.1038/s41467-024-45292-1. Nat Commun. 2024. PMID: 38383522 Free PMC article.
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
García-Roman S, Garzón-Ibáñez M, Bertrán-Alamillo J, Jordana-Ariza N, Giménez-Capitán A, García-Peláez B, Vives-Usano M, Codony-Servat J, d'Hondt E, Rosell R, Molina-Vila MÁ. García-Roman S, et al. Among authors: rosell r. Transl Oncol. 2024 Feb;40:101878. doi: 10.1016/j.tranon.2024.101878. Epub 2024 Jan 6. Transl Oncol. 2024. PMID: 38183801 Free PMC article.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Postel-Vinay S, Coves J, Texier M, Aldea M, Gazzah A, Dómine M, Planchard D, De Las Peñas R, Sala Gonzalez MA, Viteri S, Perez J, Ortega AL, Moran T, Camps C, Lopez-Martin A, Provencio M, Soria JC, Besse B, Massuti B, Rosell R. Postel-Vinay S, et al. Among authors: rosell r. Br J Cancer. 2024 Feb;130(3):417-424. doi: 10.1038/s41416-023-02514-5. Epub 2023 Dec 14. Br J Cancer. 2024. PMID: 38097741 Clinical Trial.
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC).
Rosell R, Codony-Servat J, González J, Santarpia M, Jain A, Shivamallu C, Wang Y, Giménez-Capitán A, Molina-Vila MA, Nilsson J, González-Cao M. Rosell R, et al. Crit Rev Oncol Hematol. 2024 Mar;195:104228. doi: 10.1016/j.critrevonc.2023.104228. Epub 2023 Dec 9. Crit Rev Oncol Hematol. 2024. PMID: 38072173 Free article. Review.
545 results